Ian W Flinn, MD, PhD
Director of Hematologic Malignancy Research, Sarah Cannon Blood and Marrow Transplant Program
Dr Flinn has published around 100 peer reviewed articles in international journals. His research interest is in developing new therapies for patients with lymphoma and CLL. This research includes new chemotherapeutic, immunologic and transplant approaches to these diseases.
He is a member of the CLL Research Consortium, the American Society of Oncology, the American Society of Hematology, and the American College of Physicians.